This week, Donald Trump called for Republicans to “nationalize” the upcoming elections—even though state and local officials are charged with this role. Panelists on Washington Week With The Atlantic ...

A young woman undergoes a psychiatric evaluation before her sentencing in an unusual murder trial. But as the tests become more personal and frightening, she begins to question the true motives of her ...

This is read by an automated voice. Please report any issues or inconsistencies here. Animation is the backbone of the film industry, boosting the global box office year after year. But such ...

Suchandrima Bhowmik has written over 300 articles on various health conditions, medical news, and recent breakthroughs. Her work appears in several publications, including Medical News Today, ...

The Pixar Era kicked off 30 years ago with the first installment of the popular franchise. It’s given us countless hits, but something has also been lost. By Maya Phillips There are so many ways of ...

Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...

Complement 3 glomerulopathy (C3G) is a rare kidney disease that affects your body’s innate immune system (complement system). Complement 3 glomerulopathy (C3G) is a kidney disease that’s caused by ...

This image shows a comparison between the synthetic biology–engineered plant (right) and the wild-type plant. Dr. Liao’s team has developed a novel “McG plant” with a mechanism that recycles the ...

In the heated debates over trade policy in Washington and beyond, tariffs are often portrayed as the primary—or even the sole—instrument by which governments intervene in global commerce. They are ...

EXCLUSIVE: In a highly competitive situation, New Regency has landed Fixation, an erotic thriller spec from Wednesday scribes Erika Vazquez & Siena Butterfield, Deadline has learned. Pic will be ...

Centauri plans the progression of lead candidate, an immunotherapy based broad-spectrum antimicrobial, to a first in human clinical study in early 2026 CARB-X’s additional funding brings their ...

Centauri Therapeutics Limited ('Centauri'), an immunotherapy company with a unique and proprietary platform technology applicable across a wide range of therapeutic indications, announced today that ...